598 results on '"Kaji, Kosuke"'
Search Results
2. Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity
3. Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis
4. Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin
5. Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice
6. Therapies for Alcohol-Related Liver Disease and for Non-Alcoholic Fatty Liver Disease
7. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis
8. Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis.
9. Protein-losing gastroenteropathy complicated with asymptomatic primary biliary cholangitis, refractory to immunosuppressant, and improved by Helicobacter pylori eradication: a case report
10. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus‐related liver cirrhosis
11. TOP-096 Glucagon-like peptide-1 receptor agonist, semaglutide attenuates liver cirrhosis-related skeletal muscle atrophy in diabetic mice
12. Impact of the COVID‐19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single‐center retrospective study in Japan
13. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment
14. Treatment of Hepatic Encephalopathy
15. Diagnosis of Hepatic Encephalopathy
16. Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats
17. Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator in the Cancer Microenvironment
18. Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis
19. Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis
20. The Effects of Entecavir and Tenofovir Alafenamide Fumarate Treatment on Renal Function in Japanese Elderly Patients with Chronic Hepatitis B
21. Plasma copeptin concentration is a predictor of tolvaptan efficacy in patients with hepatic ascites
22. APRI has Utility as a Biomarker of COVID‐19 Severity in Patients with Nonalcoholic Fatty Liver Disease
23. Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis
24. <Book reviews>YOKOTA Fuyuhiko, The Study of Book Culture in Early Modern Japan
25. ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis.
26. Effects of entecavir and tenofovir alafenamide fumarate treatment on renal function in Japanese elderly patients with chronic hepatitis B.
27. Hemoglobin and Endotoxin Levels Predict Sarcopenia Occurrence in Patients with Alcoholic Cirrhosis
28. Black esophagus: a life-threatening adverse event associated with endoscopic retrograde cholangiopancreatography
29. Drug Delivery with Hyaluronic Acid-Coated Polymeric Micelles in Liver Fibrosis Therapy
30. Hemoglobin levels as a surrogate marker of sarcopenia in patients with liver cirrhosis
31. Can portal hypertension and hepatic decompensation be predicted?
32. Calcified mucinous adenocarcinoma of the stomach metastatic to the iris: a case report
33. Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID‐19 severity in patients with nonalcoholic fatty liver disease.
34. Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
35. The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure
36. Changes in Coagulation and Fibrinolytic Factors in Patients With Cirrhotic Refractory Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy: A Retrospective Observational Study in Japan
37. Zinc Supplementation and an Improved Quality of Life in Patients with Autoimmune Hepatitis
38. Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
39. Diagnostic yield of liquid‐based cytology in serial pancreatic juice aspiration cytological examination
40. Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis
41. Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
42. Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis
43. Antiangiogenic Therapy for Hepatocellular Carcinoma
44. Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats
45. レンバチニブは実験的肝線維症において肝星細胞の活性化と類洞毛細血管化を阻害することにより肝線維化を抑制する。
46. Efficacy of a dedicated plastic stent in endoscopic ultrasound-guided hepaticogastrostomy during the learning curve: cumulative multi-center experience
47. Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis
48. <Articles>A Study of Gion and the Adopted Daughters who were Separated from Their Parents for Life in the Late Edo Period (Special Issue : Gender)
49. This title is unavailable for guests, please login to see more information.
50. Combined treatment with dipeptidyl peptidase‐4 inhibitor (sitagliptin) and angiotensin‐II type 1 receptor blocker (losartan) suppresses progression in a non‐diabetic rat model of steatohepatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.